title: Predictive biomarkers may help individualize treatment for patients with follicular lymphoma.
authors.forename: Mary Kay
authors.initials: MK
authors.lastname: Barton
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage; D015703:Antigens, CD / Q000378:metabolism*; D015214:Antigens, Differentiation, Myelomonocytic / Q000378:metabolism*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000235:genetics / Q000378:metabolism*; D001897:Boronic Acids / Q000008:administration & dosage; D000069286:Bortezomib; D006801:Humans; D008224:Lymphoma, Follicular / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism; D057285:Precision Medicine; D046988:Proteasome Endopeptidase Complex / Q000235:genetics*; D011719:Pyrazines / Q000008:administration & dosage; D000069283:Rituximab; D000097382:CD68 Molecule
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D015703:Antigens, CD; D015214:Antigens, Differentiation, Myelomonocytic; D014408:Biomarkers, Tumor; D001897:Boronic Acids; D000069286:Bortezomib; D046988:Proteasome Endopeptidase Complex; D011719:Pyrazines; D000069283:Rituximab; C067980:CD68 antigen, human; D000097382:CD68 Molecule; C577981:PSMB1 protein, human